# Docetaxel, Oxaliplatin and S-1 (DOS) for Advanced Gastric Cancer

> **NCT00525005** · PHASE2 · COMPLETED · sponsor: **Hallym University Medical Center** · enrollment: 44 (actual)

## Conditions studied

- Stomach Neoplasms

## Interventions

- **DRUG:** DOS (Docetaxel, Oxaliplatin and S-1)

## Key facts

- **NCT ID:** NCT00525005
- **Lead sponsor:** Hallym University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2012-09-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00525005

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00525005, "Docetaxel, Oxaliplatin and S-1 (DOS) for Advanced Gastric Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00525005. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*